Related Experiment Video

Updated: Oct 25, 2025

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform
07:13

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform

Published on: April 12, 2021

4.6K

Medication adherence in cardiovascular medicine

Steven T Simon1, Vinay Kini2, Andrew E Levy2,3

  • 1Division of Cardiology, University of Colorado Anschutz Medical Campus, Aurora, CO, USA Steven.Simon@cuanschutz.edu.

BMJ (Clinical Research Ed.)
|August 12, 2021
PubMed

Insights

Improving medication adherence in cardiovascular disease patients is crucial. Strategies like education, reminders, and cost reduction show promise in clinical trials for better patient outcomes.

Area of Science:

  • Cardiology
  • Pharmacology
  • Public Health

Background:

  • Cardiovascular disease (CVD) is the primary global cause of mortality.
  • Pharmacological treatments have advanced, yet patient non-adherence to medication hinders outcomes.
  • Medication adherence is a critical factor in managing cardiovascular health.

Purpose of the Study:

  • To review clinical trials on strategies enhancing medication adherence in cardiovascular disease patients.
  • To analyze the effectiveness of various interventions aimed at improving treatment compliance.
  • To identify future research directions for optimizing medication adherence in CVD management.

Main Methods:

  • Systematic review of clinical trials focused on medication adherence interventions.
  • Categorization of strategies including patient education, reminders, behavioral interventions, cost reduction, team-based care, and dosing simplification.
  • Analysis of reported impacts of these strategies on adherence rates.

Main Results:

  • Multiple strategies demonstrate potential to improve medication adherence in CVD patients.
  • Interventions targeting education, reminders, cost, and care coordination show varying degrees of success.
  • Specific trial outcomes highlight the impact of different approaches on patient compliance.

Conclusions:

  • Improving medication adherence is essential for mitigating cardiovascular disease burden.
  • A multifaceted approach combining various strategies is likely necessary for optimal results.
  • Further research is needed to refine and implement effective adherence interventions for long-term cardiovascular health.

More Related Videos

Using Continuous Data Tracking Technology to Study Exercise Adherence in Pulmonary Rehabilitation09:42

Using Continuous Data Tracking Technology to Study Exercise Adherence in Pulmonary Rehabilitation

Published on: November 8, 2013

13.7K
A Novel Digital Platform for a Monitored Home-based Cardiac Rehabilitation Program04:24

A Novel Digital Platform for a Monitored Home-based Cardiac Rehabilitation Program

Published on: April 19, 2019

12.0K

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
75
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
54
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
73
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
77
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
67
Drug Therapy01:28

Drug Therapy

The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
122